Multiple inflammatory and viral pathways and gut microbiota

The term Multiple inflammatory and viral pathways and gut microbiota refers to a complex physiological axis rather than a single molecular target. This conceptual framework involves the bidirectional communication between the host's innate and adaptive immune systems, various viral replication cycles, and the diverse community of microorganisms residing in the gastrointestinal tract (NIH, 2023). The gut microbiota plays a crucial role in modulating systemic inflammation and priming the immune system against viral pathogens through the production of metabolites such as short-chain fatty acids (SCFAs) and the activation of pattern recognition receptors (PubMed, 2022). Dysregulation of these pathways is implicated in a wide range of conditions, including COVID-19, inflammatory bowel disease, and metabolic syndrome (Nature Reviews Microbiology, 2021). Because this term aggregates numerous distinct enzymes, receptors, and biological entities, it is considered a systemic biological process rather than a discrete site for drug action.

Other names

Gut-immune axisGut-lung axis (in viral context)Microbiome-inflammation axis

Not applicable as this is a multi-component biological system rather than a single therapeutic target.